Oil from the marine zooplankton Calanus finmarchicus improves the cardiometabolic phenotype of diet-induced obese mice

British Journal of Nutrition

Volumn 110, Issue 12, 2013, Pages 2186-2193

  Höper, Anje C ^a   Salma, Wahida ^a   Khalid, Ahmed M ^a   Hafstad, Anne D ^a   Sollie, Selene J ^a   Raa, Jan ^b   Larsen, Terje S ^a   Aasum, Ellen ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b NONE   (Norway)

Author keywords

Abdominal obesity; Inflammation; Insulin resistance; n 3 PUFA

Indexed keywords

ADIPONECTIN; ANTIOXIDANT; CALANUS OIL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OIL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALANUS FINMARCHICUS; CALORIC INTAKE; CELL INFILTRATION; CELL SIZE; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY LIVER; GENE EXPRESSION; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; WEIGHT GAIN; ZOOPLANKTON;

ABDOMINAL FAT; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL PRODUCTS; CARDIOVASCULAR DISEASES; COPEPODA; CYTOKINES; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FATTY LIVER; GLUCOSE INTOLERANCE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; RNA, MESSENGER; WEIGHT GAIN; ZOOPLANKTON;

EID: 84889254585     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513001839     Document Type: Article

References (45)

1. Cornier MA, Despres JP, Davis N, et al. (2011) Assessing adiposity: A scientific statement from the American Heart Association. Circulation 124, 1996-2019.
2. Hossain P, Kawar B & El NM (2007) Obesity and diabetes in the developing world - A growing challenge. N Engl J Med 356, 213-215.
3. Cinti S, Mitchell G, Barbatelli G, et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46, 2347-2355.
4. Hotamisligil GS, Shargill NS & Spiegelman BM (1993) Adipose expression of tumor necrosis factor-Alpha: Direct role in obesity-linked insulin resistance. Science 259, 87-91.
5. van Erk MJ, Wopereis S, Rubingh C, et al. (2010) Insight in modulation of inflammation in response to diclofenac intervention: A human intervention study. BMC Med Genomics 3, 5.
6. Gregor MF & Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415-445.
7. Pereira MA, Kottke TE, Jordan C, et al. (2009) Preventing and managing cardiometabolic risk: The logic for intervention. Int J Environ Res Public Health 6, 2568-2584.
8. Larsen R, Eilertsen KE & Elvevoll EO (2011) Health benefits of marine foods and ingredients. Biotechnol Adv 29, 508-518.
9. Melle W, Ellertsen B & Skjoldal HR (2004) Zooplankton: The link to higher trophic levels. In The Norwegian Sea Ecosystem, pp. 148-149 [HR Skjoldal, editor]. Trondheim: Tapir Academic Press.
10. Eilertsen KE, Maehre HK, Jensen IJ, et al. (2012) A wax ester and astaxanthin-rich extract from the marine copepod Calanus finmarchicus attenuates atherogenesis in female apolipoprotein E-deficient mice. J Nutr 142, 508-512.
11. Matthews JN, Altman DG, Campbell MJ, et al. (1990) Analysis of serial measurements in medical research. BMJ 300, 230-235.
12. Xu H, Barnes GT, Yang Q, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance. J Clin Invest 112, 1821-1830.
13. Hafstad AD, Khalid AM, Hagve M, et al. (2009) Cardiac peroxisome proliferator-Activated receptor-Alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss. Cardiovasc Res 83, 519-526.
14. Kuk JL, Katzmarzyk PT, Nichaman MZ, et al. (2006) Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring) 14, 336-341.
15. Wang Y, Rimm EB, Stampfer MJ, et al. (2005) Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81, 555-563.
16. Belzung F, Raclot T & Groscolas R (1993) Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol 264, R1111-R1118.
17. Ruzickova J, Rossmeisl M, Prazak T, et al. (2004) Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39, 1177-1185.
18. Raclot T, Groscolas R, Langin D, et al. (1997) Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 38, 1963-1972.
19. Sato A, Kawano H, Notsu T, et al. (2010) Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: Importance of hepatic lipogenesis. Diabetes 59, 2495-2504.
20. Perez-Matute P, Perez-Echarri N, Martinez JA, et al. (2007) Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: Role of apoptosis, adiponectin and tumour necrosis factor-Alpha. Br J Nutr 97, 389-398.
21. Baillie RA, Takada R, Nakamura M, et al. (1999) Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-3 by dietary fish oil: A mechanism for decreased body fat deposition. Prostaglandins Leukot Essent Fatty Acids 60, 351-356.
22. Arai T, Kim HJ, Chiba H, et al. (2009) Anti-obesity effect of fish oil and fish oil-fenofibrate combination in female KK mice. J Atheroscler Thromb 16, 674-683.
23. Gorreta F, Bernasconi G, Galliani G, et al. (2002) Wax esters of n-3 polyunsaturated fatty acids: A new stable formulation as a potential food supplement. 1 - Digestion and absorption in rats. Lebensm Wiss Technol 35, 458-465.
24. Whelan J, Gouffon J & Zhao Y (2012) Effects of dietary stearidonic acid on biomarkers of lipid metabolism. J Nutr 142, 630S-634S.
25. Voss AC & Sprecher H (1988) Metabolism of 6,9,12-octadecatrienoic acid and 6,9,12,15-octadecatetraenoic acid by rat hepatocytes. Biochim Biophys Acta 958, 153-162.
26. Parrish CC, Pathy DA, Parkes JG, et al. (1991) Dietary fish oils modify adipocyte structure and function. J Cell Physiol 148, 493-502.
27. Lee MS, Kwun IS & Kim Y (2008) Eicosapentaenoic acid increases lipolysis through up-regulation of the lipolytic gene expression and down-regulation of the adipogenic gene expression in 3T3-L1 adipocytes. Genes Nutr 2, 327-330.
28. Lorente-Cebrian S, Bustos M, Marti A, et al. (2012) Eicosapentaenoic acid inhibits tumor necrosis factor-A-induced lipolysis in murine cultured adipocytes. J Nutr Biochem 23, 218-227.
29. Rustan AC, Hustvedt BE & Drevon CA (1993) Dietary supplementation of very long-chain n-3 fatty acids decreases whole body lipid utilization in the rat. J Lipid Res 34, 1299-1309.
30. Berger JJ & Barnard RJ (1999) Effect of diet on fat cell size and hormone-sensitive lipase activity. J Appl Physiol 87, 227-232.
31. Ren T, He J, Jiang H, et al. (2006) Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-Alpha or isoproterenol. J Mol Endocrinol 37, 175-183.
32. Ikeuchi M, Koyama T, Takahashi J, et al. (2007) Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem 71, 893-899.
33. Looije NA, Risovic V, Stewart DJ, et al. (2005) Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model. J Pharm Pharm Sci 8, 400-408.
34. Thornton SJ, Warburton C, Wasan KM, et al. (2007) Treatment with a cholesterol absorption inhibitor (FM-VP4) reduces body mass and adipose accumulation in developing and pre-obese mice. Drug Dev Ind Pharm 33, 1058-1069.
35. Weisberg SP, McCann D, Desai M, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808.
36. Calder PC (2013) Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? Br J Clin Pharmacol 75, 645-662.
37. Arunkumar E, Bhuvaneswari S & Anuradha CV (2012) An intervention study in obese mice with astaxanthin, a marine carotenoid - effects on insulin signaling and proinflammatory cytokines. Food Funct 3, 120-126.
38. Yuan JP, Peng J, Yin K, et al. (2011) Potential health-promoting effects of astaxanthin: A high-value carotenoid mostly from microalgae. Mol Nutr Food Res 55, 150-165.
39. Ye J, Gao Z, Yin J, et al. (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293, E1118-E1128.
40. Ouchi N, Parker JL, Lugus JJ, et al. (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11, 85-97.
41. Bruun JM, Lihn AS, Verdich C, et al. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285, E527-E533.
42. Lamping K, Nuno D, Coppey L, et al. (2013) Modification of high saturated fat diet with n-3 polyunsaturated fat improves glucose intolerance and vascular dysfunction. Diabetes Obes Metab 15, 144-152.
43. Preuss HG, Echard B, Yamashita E, et al. (2011) High dose astaxanthin lowers blood pressure and increases insulin sensitivity in rats: Are these effects interdependent? Int J Med Sci 8, 126-138.
44. Yang ZH, Miyahara H, Mori T, et al. (2011) Beneficial effects of dietary fish-oil-derived monounsaturated fatty acids on metabolic syndrome risk factors and insulin resistance in mice. J Agric Food Chem 59, 7482-7489.
45. Gillingham LG, Harris-Janz S & Jones PJ (2011) Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 46, 209-228.